2-amino-5-phosphonovalerate has been researched along with Insulin Resistance in 1 studies
2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collison, KS | 1 |
| Inglis, A | 1 |
| Shibin, S | 1 |
| Andres, B | 1 |
| Ubungen, R | 1 |
| Thiam, J | 1 |
| Mata, P | 1 |
| Al-Mohanna, FA | 1 |
1 other study available for 2-amino-5-phosphonovalerate and Insulin Resistance
| Article | Year |
|---|---|
Differential effects of early-life NMDA receptor antagonism on aspartame-impaired insulin tolerance and behavior.
Topics: 2-Amino-5-phosphonovalerate; Animals; Animals, Newborn; Aspartame; Behavior, Animal; Blood Glucose; | 2016 |